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Abstract 
Background: Youth involved in the juvenile justice system (YIJJ) have high rates of substance use problems; how-
ever, rates of YIJJ engagement in substance use services is low. Barriers to service engagement include lack of appro-
priate screening and connection to services by the juvenile justice system, as well as lack of resources for delivering 
evidence-based treatment in community-based settings. To address these barriers, this paper describes a protocol 
for a type 1 hybrid design to (1) implement universal substance use screening for YIJJ; (2) implement and evaluate 
the feasibility and effectiveness of a brief, three-session substance use interventions based in motivational interview-
ing for youth with mild/moderate substance use: Teen Intervene (an individual-based intervention); (3) implement 
ENCOMPASS, an evidence-based substance use intervention based in motivational enhancement and cognitive 
behavioral therapy for youth with severe substance use; and (4) evaluate facilitators and barriers to implementing 
these interventions for mild to severe substance use among YIJJ in community mental health centers (CMHC).
Methods/design: Using a hybrid type 1 clinical effectiveness-implementation design, we will collaborate with 
CMHCs and juvenile justice in two rural Indiana counties. Guided by the EPIS (exploration, preparation, implementa-
tion, sustainability) framework, we will measure factors that affect implementation of substance use screening in 
juvenile justice and implementation of substance use interventions in CMHCs utilizing self-reports and qualitative 
interviews with juvenile justice and CMHC staff pre- and post-implementation. YIJJ with mild/moderate substance 
use will receive a brief interventions and YIJJ with severe substance use will receive ENCOMPASS. We will measure 
the effectiveness of a brief and comprehensive intervention by assessing changes in substance use across treatment. 
We anticipate recruiting 160 YIJJ and their caregivers into the study. We will assess intervention outcomes utilizing 
baseline, 3-, and 6-month assessments.
Discussion: Findings have the potential to improve screening and intervention services for YIJJ.
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Hybrid design, Effectiveness
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Background
Youth involved in the juvenile justice system (YIJJ) pre-
sent with substance use disorders (SUDs) and mental 
health problems at significantly higher rates than non-
offending peers in the community [1–4]. Though esti-
mates vary by population characteristics and assessment 
criteria [5], up to 80% of justice-involved youth report 
lifetime substance use; moreover, between up to 40% of 
justice-involved youth meet criteria for a SUD [3, 6, 7], 
and a significant portion of youth offenders suffer mul-
tiple comorbid mental health disorders and SUDs [2, 8]. 
Arrested youth also initiate substance use earlier than 
other adolescents, which increases risk of developing 
more severe substance use problems [5]. While can-
nabis and alcohol are the most widely used substances 
among both justice-involved and non-justice involved 
adolescents, justice-involved youth use more dangerous 
drugs, such as opioids, at higher rates compared to their 
non-justice-involved peers [9]. Despite this significant 
behavioral health burden, YIJJ access behavioral health 
(mental health and substance use) services at low rates, 
and at much lower rates than non-offending peers [10]. 
For example, in one large scale study of youth offend-
ers, well under 20% of detained youth were engaged in 
behavioral health treatment at 60 days following release 
to the community [6]. Effective evidence-based inter-
ventions targeting behavioral health among YIJJ exist 
[11–17]; however, only a relatively small number of com-
munities have access to these programs, contributing to 
the findings that of the small sample of YIJJ who engage 
in behavioral health treatment, most do not receive evi-
dence-based treatment [14]. The goal of this manuscript 
is to describe a protocol to implement substance use 
screening in juvenile justice settings and evidence-based 
substance use interventions in community mental health 
centers targeting YIJJ.
Barriers to engagement in substance use and behavioral 
health treatment
There are multiple barriers that prevent YIJJ from engag-
ing in substance use—and other behavioral health—
treatment; however, for the purposes of the proposed 
study, we highlight barriers at the level of the juvenile jus-
tice system related to screening and identification of YIJJ 
in need of services, and barriers at the community level 
in regards to providing appropriate and evidence-based 
services.
Substance use screening in the juvenile justice system
First, there is a lack of systematic mental health and 
substance use screening in the juvenile justice system 
[18]. Given the high rates of substance use and mental 
health problems among YIJJ, as well as the higher risk 
of recidivism among YIJJ with substance use and mental 
health problems, screening and identifying those in need 
of services is an important task for juvenile justice staff 
[6, 18–20]. Although juvenile probation officers (JPO) 
typically function as gatekeepers who help connect YIJJ 
with appropriate services, there is often a significant lag 
time between YIJJ’s release from detention and their first 
contact with a JPO, which leads to delays in service con-
nection and engagement. Moreover, arrest and detention 
can be viewed as a “crisis event” for youth during which 
time their motivation for seeking behavioral health ser-
vices is high; therefore, screening and identification of 
service needs and connection to services is crucial during 
the initial intake period following arrest [21]. Thus, we 
propose to implement universal substance use screening 
in juvenile justice settings during initial intake following 
arrest in order to increase identification of YIJJ in need of 
services and in turn increase referral and connection to 
appropriate services in community-based settings.
Evidence‑based substance use interventions in community 
mental health centers
Although evidence-based interventions (EBI) for sub-
stance use targeting YIJJ exist [22], high-quality EBIs 
often are not available in community mental health 
centers (CMHC). In addition to lack of dissemina-
tion and implementation of EBIs in CMHCs, there is 
also a shortage of behavioral health providers and clini-
cians in community-based settings to provide these ser-
vices, and caseloads often are too large to implement 
intensive treatments [23, 24]. Therefore, there is a need 
for implementation of cost-effective, feasible EBIs that 
appropriately address substance use with YIJJ in commu-
nity-based settings.
In accordance with the substance use care continuum 
[25], we propose to implement both brief and more 
comprehensive substance use interventions in CMHCs 
in order to address the heterogeneity in substance use 
severity. Implementing EBIs for varying levels of sub-
stance use risk ensures that lower risk individuals are 
not assigned to a higher level of care than necessary, as 
this creates a burden on the individual receiving treat-
ment and reduces treatment engagement. Further, brief 
interventions are also cost-effective, and since they can 
be implemented by professionals with a range of training 
background, this limits the burden on community-based 
behavioral health providers by distributing workload 
across all personnel [26].
We propose to examine the effectiveness of an indi-
vidual-based brief intervention, Teen Intervene [27, 28], 
which is based in motivational interviewing and have 
been show to effectively reduce mild to moderate sub-
stance use among adolescents and, specifically, among 
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YIJJ [29]. Teen Intervene is a manualized, three- to six-
session individual-based treatment targeting youth 
substance use that utilizes principles of motivational 
interviewing, cognitive-behavioral therapy, and self-
change principles [27, 28]. Teen Intervene has been 
shown to reduce substance use and increase motivation 
to change substance use among adolescents [28] and 
court-involved adolescents [29] with mild to moderate 
substance use.
In addition to implementing a brief intervention, we 
also will implement a more intensive, comprehensive EBI 
for YIJJ with more severe substance use problems. There 
are several empirically supported outpatient treatment 
options for adolescents with problematic substance use 
and more severe substance use disorders [30], includ-
ing cognitive behavioral therapy (CBT), motivational 
enhancement treatment (MET), and contingency man-
agement (CM). Moreover, these EBIs have been shown 
to be effective in reducing substance use when deliv-
ered in combination, such as MET combined with CBT 
and contingency management (MET/CBT + CM). One 
such integrated intervention model, ENCOMPASS, is a 
manualized outpatient intervention that combines MET/
CBT + CM and pharmacotherapy to treat adolescents 
with co-occurring substance use and common men-
tal health disorders (e.g., depression, attention-deficit/
hyperactivity disorder). ENCOMPASS has been imple-
mented in three randomized controlled clinical trials in 
youth who met criteria for an average of three substance 
use disorders and two to three psychiatric disorders 
[31–33]. Collectively, results demonstrated significant 
reduction in both substance use and mental health dis-
order severity—with outcomes comparable or superior to 
outcomes from trials for separate or sequential substance 
use or mental health treatments. ENCOMPASS also 
entails pharmacotherapy, which may include medication 
assisted treatment for more severe substance use, such as 
opioid use or alcohol. YIJJ are more likely to use opioids 
and have more severe substance use problems compared 
to non-offending peers [9]; thus, implementation of EBIs 
that include medication assisted treatment is important 
given the effectiveness of medication assisted treatment 
for adolescents with opioid use disorder [34–36].
Overview of study design and objectives
In order to address service connection and availabil-
ity of community-based substance use EBIs for YIJJ, we 
propose to partner with community mental health 
centers and juvenile justice systems in two Midwest-
ern counties to: (1) implement universal substance use 
screening for probation youth (at the point of arrest) to 
determine substance use risk level and appropriate treat-
ment needed; (2) implement and evaluate the feasibility 
and effectiveness of a brief substance use intervention 
for youth with mild/moderate substance use problems 
in community mental health centers; and (3) imple-
ment a comprehensive adolescent-specific evidence-
based substance use treatment in community mental 
health centers. We propose to utilize a hybrid type 1 
clinical-effectiveness-implementation trial [37] in order 
to evaluate facilitators and barriers to implementing this 
approach as well as test the effectiveness of these inter-
ventions in reducing substance use among YIJJ.
Method
Implementation model
Implementation will be guided by the Exploration, 
Preparation, Implementation, and Sustainment (EPIS) 
framework to study how best to implement the bun-
dled treatment approach in juvenile justice settings and 
CMHCs [38]. We will utilize the Stages of Implemen-
tation Completion (SIC) implementation approach 
to measure inner and outer context factors that affect 
implementation of best-practices [38–41]. The outer con-
text, in this case, includes state and local policies regard-
ing funding and provision of addiction services for youth 
in general and, specifically, for justice involved youth. 
Inner context includes the organizations climate, culture, 
staffing as well as characteristics of juvenile justice and 
community mental health center (CMHC) staff towards 
adolescents (see Fig. 1 for illustration of EPIS model). The 
EPIS framework also explicitly identifies project phases, 
including exploratory phases, which is useful in the con-
ceptualization of our pilot project. To guide and assess 
implementation we will collect data from self-report sur-
veys and interviews conducted with substance use pro-
viders, parents, youth and court personnel across the 
study period.
Study setting
Two counties in a Midwest state were chosen based on 
high rates of substance-related arrests and rates of sub-
stance use among adolescents in the community. Coun-
ties were chosen given their small size as well as the 
presence of one primary community mental health center 
(CMHC) that is designated to serve the community. This 
allows for feasibility of building and strengthening rela-
tionships between juvenile justice and community mental 
health professionals/agencies.
Participants
YIJJ and caregivers
We will recruit YIJJ aged 14–17 in one of two coun-
ties who are either detained in the detention center 
and returning to the community or currently in the 
Page 4 of 11Aalsma et al. Addict Sci Clin Pract           (2019) 14:36 
community. Eligible youth will be those who are iden-
tified as having a history of substance use, based on 
screening done by the juvenile justice staff (see below for 
explanation). Both youth and their legal guardian must 
agree to participate. Only youth and caregivers who are 
fluent in English will be eligible to participate.
Community partner participants
Community partner participants will be clinicians, case 
managers, and supervisors working in the CMHC in each 
county (range n = 10–30). Bachelor’s level case manag-
ers from each CMHC site (n = 2 case managers for each 
county) will be recruited to act as intervention special-
ists. They will be trained in the brief intervention and 
provide treatment to YIJJ and their caregivers. Master’s 
level licensed clinicians from each CMHC (n = 2 for each 
county) will be trained in the comprehensive substance 
use intervention and provide treatment to YIJJ.
The juvenile justice system in each county have agreed 
to participate and implement substance use screening. 
Designated juvenile probation officers/intake officers 
will be identified and will be responsible for conducting 
universal substance use screening with all youth coming 
through the detention center at intake.
In addition to these primary individuals who will pro-
vide interventions, we will seek participation from other 
personnel (e.g., juvenile justice intake staff, CMHC 
supervisors) who are involved in the implementation and 
sustainability of the interventions to complete qualitative 
interviews and quantitative measures to assess feasibility 
and implementation in these settings.
Training and fidelity monitoring
Juvenile justice substance use screening
We will conduct a one-time training for juvenile proba-
tion officers at each of the JJ system sites to train them on 
the substance use screening tool (see below for details). 
Fig. 1 EPIS implementation model
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Training is minimal compared to the intervention train-
ing given the ease/usability of the measure.
Interventions
Prior to the start of the trial, therapists and interven-
tion specialists at each of the two sites will be trained 
by respective intervention training teams (i.e., training 
team for Teen Intervene and ENCOMPASS). Bach-
elor’s level brief intervention specialists will be trained 
in the brief interventions. For the purposes of wider 
dissemination of these evidence-based brief interven-
tions, non-research providers at each CMHC also will 
have the opportunity to receive initial training. Follow-
ing a one-time initial training, brief intervention spe-
cialists will have monthly meetings with the training 
team for ongoing training, consultation, and fidelity 
monitoring. Master’s level therapists who will be des-
ignated as ENCOMPASS therapists at each of the sites 
will be trained in ENCOMPASS by the ENCOMPASS 
master trainers. Following initial in-person training, 
ENCOMPASS therapists will engage in weekly meet-
ings with the ENCOMPASS trainers for ongoing train-
ing, consultation, and fidelity monitoring. Psychotropic 
medication prescribers are also engaged in the weekly 
meetings and supervision is provided by an adolescent 
addiction psychiatrist.
Fidelity monitoring Fidelity monitoring for the brief 
intervention and ENCOMPASS will be conducted by the 
respective intervention trainers.
Teen Intervene Brief intervention specialists will com-
plete self-rating checklists following each session and also 
audiotape sessions to be rated by Teen Intervene trainers 
for fidelity [28]. Therapists and raters will complete the 
same checklists, which include items related to module-
specific activities as well as items related to adherence 
to principles of motivational interviewing (e.g., reinforc-
ing change talk) and cognitive behavioral techniques 
(e.g., assigning homework). Items are rated on a 5-point 
scale, with higher scores denoting greater fidelity/adher-
ence and competency in skills. Mean scores of 3 across all 
items denote sufficient competency and fidelity.
ENCOMPASS ENCOMPASS therapists will complete 
self-rating treatment adherence fidelity checklists fol-
lowing each session as well as audio record sessions to 
be reviewed by ENCOMPASS trainers for fidelity checks. 
The same checklist will be used by therapists and raters 
to measure adherence and consists of six items related 
to principles of cognitive behavioral therapy six items 
related to principle motivational interviewing and moti-
vational enhancement techniques, as well as items related 
to module-specific tasks and activities. Therapists self-
rate their performance for each session in each of these 
areas on a 6-point scale (0 = not completed, 1 = low skill 
level to 5 = high skill level); thus, fidelity to the treatment 
can be quantified as an overall mean score for each ses-
sion. Overall mean scores of 3 or above on the self-rat-
ing forms and/or trainer ratings of audiotaped sessions 
will be considered meeting minimum fidelity/adherence 
standards [32, 33].
Procedures
Screening and referral
Juvenile probation officers will screen all youth who come 
through the intake process at the detention center using 
the CRAFFT [42]. The CRAFFT consists of six yes or 
no questions regarding substance use (e.g., do you ever 
use alcohol or drugs to relax; has family ever been con-
cerned about your alcohol or drug use) as well as ques-
tions regarding frequency of past year substance use, 
with higher scores (range 0–6) denoting more severe 
substance use problems (see Additional file  1: Appen-
dix S1 for complete measure). The CRAFFT has been 
shown to be an effective clinical tool in identifying sub-
stance use risk level among children and adolescents [41]. 
The research team will be notified of any youth scor-
ing at least a 1 on the CRAFFT measure. Participants 
also will be notified of the opportunity to participate in 
an intervention and will be told that they might be con-
tacted regarding voluntary participation in a research 
study. The research team will contact potentially eligible 
participants.
Enrollment and baseline assessment
Following initial recruitment, research assistants will 
complete consent/assent with the caregiver/youth at 
their home or preferred location. As part of the consent 
process, participants will be told that this is an interven-
tion study and that they might be assigned to different 
interventions. Participants and their caregivers also will 
complete a baseline assessment, which includes self-
report measures of demographics, family functioning, 
mental health, substance use (see Table 1 for overview of 
all measures).
Risk level determination
Based on the youth’s initial CRAFFT score as well as 
their scores on initial baseline measures collected after 
consent at the first/baseline visit, youth will be catego-
rized as either low to mid-risk or high-risk based on 
criteria from the American Society of Addiction Medi-
cine (ASAM). ASAM criteria utilizes six dimensions of 
an individual’s substance use and overall functioning to 
determine appropriate level of care [25]. We will deter-
mine risk level based on youth’s pattern of substance 
use, such as frequency and quantity of use, as well as 
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problematic use based on DSM-5 substance use disorder 
symptoms. Table 2 describes specific risk determination 
criteria we will determine based on assessment. Gener-
ally, high-risk youth will be those who have identified 
past year repeated use of more lethal substances with a 
high risk for overdose and withdrawal potential (e.g., opi-
oids, methamphetamine) and those who endorse three or 
more DSM-5 SUD symptoms, which is consistent with a 
moderate to severe SUD. All other youth initially will be 
randomized to one of the brief interventions. Based on 
preliminary data collected from each county, it is esti-
mated that about 10% of youth will be in the high-risk 
group.
Following determination of risk level, high-risk youth 
will be assigned to complete ENCOMPASS, the com-
prehensive substance use treatment. Youth who are 
categorized as low- or mid-risk will be randomly assigned 
to one of the two brief interventions. Following rand-
omization, youth will engage in either Teen Intervene or 
Family Check-Up with a brief intervention specialist.
Measuring treatment response Following completion 
of the first round of brief interventions (three sessions 
of Teen Intervene), we will measure youth’s response to 
treatment. Treatment response will be measured utilizing 
the Brief Situational Confidence Questionnaire (BSCQ), 
an eight item self-report measure of one’s level of confi-
dence in resisting urges to use substances in eight situa-
tions: unpleasant emotions, physical discomfort, pleasant 
emotions, testing of control, urges and temptations, con-
flict with others, social pressures, and pleasant times with 
others [42]. Individuals rate their confidence in abstaining 
Table 1 Overview of data collection
All measures are self-report unless noted otherwise
Informant Content Time of Completion
Implementation measures
System-level implementation CMHC staff, JJ staff, 
supervisors
Implementation Citizenship Behavior Scale [47], Implementa-
tion Climate Scale [48], Implementation Leadership Scale 
[49], Organizational Readiness to Implement Change (ORIC) 
[50]
Qualitative interviews
Pre-, post-implementation
JJ staff, supervisors Qualitative interviews Pre-, post-implementation
Intervention fidelity monitor-
ing/adherence
Intervention providers Brief intervention fidelity self-rating checklists
ENCOMPASS treatment adherence checklist
Weekly
Intervention trainers Fidelity monitoring checklists based on therapist recorded 
sessions
Monthly
Treatment satisfaction Parent, youth Service Satisfaction Scale [51] 1-month post-intervention
Treatment response Youth BSCQ [42], FCU Clinical Monitoring Report [43], BSTAD [52] Post 1st and 2nd intervention
Participant-level measures
Demographics Youth, parent Family affluence [53], Family characteristics Baseline
Substance use Youth CRAFFT [50], BSCQ [51], BSTAD, AUDIT-C [54] Baseline, 3-, 6-months
Family functioning Youth, parent Parental Monitoring Scale [55] Baseline, 3-, 6- months
Health service use history Parent Baseline, 3-, 6-months
Psychosocial functioning Youth, parent Difficulties in Emotion Regulation Scale [56], Peer Conflict 
Scale [57], Hope & Life Satisfaction Scales [58]
Baseline, 3-, 6-months
Mental health Youth K-CAT (computerized child diagnostic evaluation; [59]) Baseline, 6-months
Table 2 Risk level determination
Brief intervention (low/mid risk) Comprehensive intervention (high risk)
Substance use frequency Less than weekly use of cannabis, alcohol, nicotine Weekly or more frequent use of any sub-
stance
Past year repeated use of lethal substance 
(opioids, methamphetamine, benzodiaz-
epines)
Problematic substance use Minimal problems or consequences of use
≤ 2 DSM-5 SUD symptoms
History of overdose
Report of experiencing withdrawal
≥ 3 DSM-5 SUD symptoms
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from substance use in each of the situations on a 0% (not at 
all confident) to 100% (completely confident), with higher 
scores denoting greater confidence in abstaining from 
substance use. Treatment response will be determined 
utilizing a cut-off overall mean score of 70% on the BSCQ 
(i.e., average of 70% confidence in abstaining from using 
substance use across all eight scenarios), based on results 
from previous studies utilizing the BSCQ as a measure of 
symptom improvement [43]. The cutoff of 70% has two 
advantages: it is the average treatment response expected 
for this intervention, and it yields (approximately, if the 
distribution is symmetric) an anticipated equal sample-
size split for responders and non-responders for the sec-
ond randomization. Those with a post-intervention score 
of 70% or higher will be considered “treatment responders” 
and those whose BSCQ post-intervention score is lower 
than 70% will be considered “treatment non-responders.” 
Those youth who are considered “responders” will be told 
that they have successfully completed the intervention; 
they will complete additional post-treatment measures at 
3 and 6 month follow-up. Non-responders will continue 
to the second randomization.
Following completion of treatment response meas-
ures using the BSCQ, those who are identified as “non-
responders” (i.e., mean post-test BSCQ score lower than 
70) will complete a second round of brief interventions. 
If youth continue to not respond, clinicians will make 
recommendations and referrals as appropriate. Follow-
ing completion of the second round of brief intervention, 
treatment response will be measured again using the 
BSCQ and participants will complete 3- and 6- month 
follow-up (see Fig. 2).
Ongoing data collection
In addition to the intervention, participants and their 
caregivers will complete data collection at three time 
points: baseline, 3  months, and 6  months. Parents and 
youth each will be compensated $50 at each data collec-
tion point. In addition to measures of treatment response 
as described above, participants will complete self-report 
measures of family functioning, mental health symp-
toms, other risk behaviors, and psychosocial functioning 
(see Table 1 for overview of measures). These additional 
measures will help to explore additional characteristics 
related to treatment response.
Community partners will complete pre- and post-inter-
vention measures related to feasibility of implementa-
tion and sustainability (e.g., organizational climate; see 
Table 1 for complete list of measures).
Data analysis
Measurement of intervention effectiveness and treatment 
response
Preliminary analyses Preliminary analyses will be used 
to compare the primary treatment response outcome 
(confidence of abstaining measured by the BSCQ) and 
substance use outcome across the responders and non-
responders of the brief intervention and ENCOMPASS 
at baseline, 3  months, and 6  months. A separate model 
will be utilized to measure effectiveness among those 
assigned to ENCOMPASS. Substance use will be cal-
culated as number of days in the past month of using 
alcohol, marijuana, and other substances (range 0–90). 
These outcomes will be compared between groups with 
longitudinal generalized linear models (GLM) using the 
Existing 
Resources
Positive 
CRAFFT
Intake
Youth or Parent 
Not Interested
Yes
Recruitment/Consent
Baseline 
Measurements
Research Assistant
High 
Risk
Low-
Mid 
Risk
ENCOMPASS: CMHC (16 sessions)
Teen Intervene:
Intervention Specialist
(3 sessions) Responder
Non-
Responders
Monitor 
Behavior
Fig. 2 Overview of study design. YIJJ who score 1 or more on the CRAFFT will be recruited for the study. If interested and consent to treatment, 
they will be assessed to determine risk level. YIJJ identified as high-risk youth will be assigned to complete ENCOMPASS. Low to mid risk youth will 
be assigned to the brief intervention, Teen Intervene. Following the brief intervention, we will measure treatment response using the BSCQ. YIJJ 
who score below 70% will be considered “non-responders” and referred to ENCOMPASS
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GENMOD procedure with a linear link and normal error 
distribution. The BSCQ and substance use outcome will 
be analyzed in separate models. The baseline measure of 
BSCQ or substance use days will be adjusted as covari-
ates and the repeated measurements of each outcome at 
3 months and 6 months will be analyzed simultaneously 
in the model.
The GLMs are easily fit for non-Gaussian distribu-
tions by specifying appropriate link functions and error 
distributions. If substance use days exhibit sparse counts 
or large frequency of zeros, we will consider using logis-
tic, Poisson, or zero-inflated Poisson regression models, 
depending on the observed distributions of outcome 
behaviors. We also will explore analyzing substance use 
as time-to-event data using a Cox proportional hazards 
regression model with the SAS PHREG procedure with 
censoring if loss to follow-up occurs. Effect sizes will be 
computed from the model as differences between groups 
on adjusted means divided by SDs for the linear models, 
or differences between odds for logistic models or haz-
ards for Poisson models.
The median and relevant percentile (e.g. 25th or 75th) 
of time to events will be presented by group with asso-
ciated confidence intervals. All models will include an 
indicator variable for whether the subject was enrolled 
as a detained or probation youth. Other covariates will 
be included based on their theoretical importance as 
potential confounders and on their imbalance between 
randomized arms at baseline. We also will examine mod-
erators that we have hypothesized to be potential deter-
minants of treatment response (e.g., family functioning).
Analyses The specific analyses and hypothesis tests 
(which are preliminary because this is a feasibility study) 
will assess effectiveness of the brief intervention and 
ENCOMPASS on substance use outcomes. These data 
will be used to generate hypotheses about brief and com-
prehensive interventions for a future larger study.
Sample size and power We plan to recruit n = 80 youth 
and caregiver dyads per county (160 total). We estimate 
that no more than 10% of youth in each county will be 
high-risk, resulting in a sample size of n = 16 assigned to 
ENCOMPASS and n = 144 to first-stage brief intervention 
(BI). We anticipate 20% loss at 6-month follow-up result-
ing in n = 12 in the ENCOMPASS group and n = 116 in 
the first-stage BI with 6 month data (58 responders and 
58 non-responders, assuming a 50% response rate. We 
have accounted for a sample size inflation factor related 
to potential within-county intraclass correlation (ICC) 
of outcomes. Specifically, in the first step of the back-cal-
culation, we determined that a sample size of n = 40 per 
responders and non-responders to the first-stage interven-
tion (with 6-month data) is required under the “independ-
ence of observations” assumption (i.e., before accounting 
for clustering) to provide 80% power for the two-sided 
model-based tests to detect an effect size (0.63) that is 
between medium (0.50) and large (≥ 0.80). For a first-
stage effective sample size of 40 in each group (responder 
vs. non-responder), there is a 1.39 sample size inflation 
factor (IF) when the ICC = 0.01 and the number of clus-
ters (i.e., counties) = 2: IF = [1 + (average 40 patients per 
cluster − 1) × ICC of 0.01]. Therefore, an actual sample 
size of 56 per first-stage brief intervention (i.e., 40 × 1.39) 
with 6-month data is required (i.e., an effective sample size 
of 40 per first-stage brief intervention with 6-month data 
if observations were not clustered). The sample of 56 in 
each group will provide adequate power for this feasibility 
study and its preliminary hypothesis tests, given that we 
anticipate n = 58 per first-stage group (responder vs. non-
responder) with 6-month data. This power calculation is 
conservative because the longitudinal models will have 
slightly increased power due to incorporating all avail-
able data (baseline, 3-months, 6-months), including data 
from persons missing one but not all times points. The 
goal will be to estimate effect sizes, for which the planned 
sample size will be adequate. A minimum of 12 per group 
is recommended for estimating effects sizes of continuous 
outcomes in pilot or feasibility studies [44].
Measurement of implementation in juvenile justice 
and CMHC settings
We will utilize both qualitative and quantitative meth-
ods to assess implementation of substance use screen-
ing in the juvenile justice systems and implementation 
of interventions in the CMHCs.
Stages of  implementation completion exploratory analy-
ses We will utilize the stages of implementation comple-
tion (SIC) tool to track and assess implementation progress 
separately for the CMHCs and juvenile justice settings. 
Utilizing the online SIC tracker, we will log data occurring 
at each of the implementation stages: pre-implementation 
(exploration and preparation), implementation, and sus-
tainability. The online SIC tracker computes SIC scores 
at each implementation stage for measures such as pro-
portion (percentage of planned activities performed) and 
duration (number of days between activities), which have 
been shown to predict successful achievement of imple-
mentation milestones [45, 46]; data also provides insights 
into organizational implementation behavior predicting 
sustainment.
Quantitative analysis We will conduct separate analyses 
for juvenile justice systems and CMHCs based on CMHC 
and juvenile justice staff completion of implementation 
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measures (see Table  1 for complete list of measures). We 
will use linear mixed models to analyze repeatedly meas-
ured implementation variables (baseline/pre-implementa-
tion, 6 months/post-implementation) to determine whether 
implementation variables change over time. In one model 
measuring implementation of substance use screening in 
juvenile justice settings, organizational readiness to imple-
ment change (based on juvenile justice staff self-reports) 
will serve as the dependent variable and staff and setting 
characteristics (e.g., demographics, years of experience, see 
Table 1) will serve as independent variables. Similar anal-
yses will be conducted to assess implementation with the 
CMHCs.
Qualitative analysis We will conduct separate qualita-
tive analyses for implementation of substance use screen-
ing in the juvenile justice systems and implementation 
of interventions in the CMHCs. We will separately ana-
lyze qualitative interviews with juvenile justice staff and 
CMHC staff using an inductive, interpretive approach 
based on grounded theory [47–49]. Two coders will ini-
tially review transcripts and complete open coding to 
identify emergent themes. Following open coding, coders 
will discuss findings and then complete focused coding 
utilizing a determined coding scheme based on emergent 
themes. This qualitative analysis can be viewed as a devel-
opmental approach where findings will both improve 
understanding of implementation and inform refinement 
of implementation strategies.
Discussion
Youth in the juvenile justice system (YIJJ) report high 
rates of substance use and behavioral health problems; 
however, are less likely to receive services compared to 
their non-offending peers. For one, YIJJ often are not 
appropriately screened for substance use or other behav-
ioral health problems; if they are identified as needing 
services, there are often not appropriate services avail-
able for youth in community-based settings. The project 
aims to address these barriers by utilizing a hybrid type 1 
clinical effectiveness-implementation design to (1) imple-
ment universal validated screening for substance use in 
two county juvenile justice systems, and (2) implement 
a brief intervention and a comprehensive EBI to equip 
CMHCs with appropriate EBIs to target YIJJ youth with 
a range of substance use severity. In addition to testing 
the feasibility of implementing a brief intervention and 
a communication system between juvenile justice and 
CMHCs, we also will compare the effectiveness of a com-
prehensive intervention.
This study advances research on implementation stud-
ies of interventions for YIJJ by using a risk stratification 
approach which emphasizes that treatment should be 
individualized and least restrictive as multiple barriers and 
challenges exist to engage youth and families in treatment. 
Moreover, this approach should be helpful in geographic 
areas with workforce access issues. To date, few studies have 
examined the effectiveness of evidence-based brief inter-
ventions for substance use among YIJJ. Understanding their 
effectiveness could allow for more universal dissemination 
to other justice systems.
Limitations
The project is not without limitations. For one, there is 
evidence that those youth with more severe substance 
use or behavioral health problems are even less likely 
to receive services due to a number of barriers, such as 
family functioning and environmental resources. Thus, 
given the voluntary nature of the study, it is possible that 
we will not be able to engage those particularly high-risk 
youth. Nonetheless, we will be utilizing a home-based 
model of care which should increase treatment engage-
ment and eliminate barriers such as transportation. 
Another limitation is that turnover of case managers in 
community mental health centers is high; this significant 
turnover may limit sustainability of the interventions. 
The staffing cost of continued supervision and training 
to high fidelity is a barrier to sustainment of evidence-
based treatment [50]. However, complex interventions, 
such as ENCOMPASS, are necessary with vulnerable 
populations presenting with multiple risk behaviors and 
diagnoses. Thus, sustainment and expansion of complex 
interventions are important goals for communities and 
gathering pilot data on the barriers to these interventions 
is needed to further this important work. Lastly, we are 
implementing these services in two smaller counties each 
with only one CMHC; this model of increasing commu-
nication and collaboration between the JJ system and the 
CMHC may be more challenging for larger counties with 
multiple organizations that offer treatment services.
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